昆山龙灯瑞迪制药有限公司-关于我们

Product development

The products developed by our company mainly focus on cardiovascular and cerebrovascular diseases, endocrine diseases, central nervous system diseases, skin diseases, digestive system diseases, rheumatoid diseases, AIDS, anti-tumor and other areas. So far, our company has obtained 27 marketing licenses for drugs. Relying on the strong R&D capability of the parent company, Dr. Reddy’s Laboratories Ltd. of India, our company is now developing more than 40 products, and has submitted.

While doing well in the existing products, we also continue to cooperate with medical experts in depth to explore new treatment directions for diseases, so that patients can have more and better treatment options and obtain more scientific treatment plans.

Laboratory Facilities

The R&D center has functional units that meet different R&D needs, mainly including formulation R&D laboratories, analysis laboratories, pilot workshops, and commercial scale process validation workshops. The analytical laboratory has many analytical instruments, such as advanced high performance liquid chromatograph, gas chromatograph, diode display detector, automatic potentiometric titration, Malvern laser particle size analyzer, automatic dissolution tester, ultraviolet spectrophotometer, infrared spectrophotometer, near-infrared spectrophotometer, proton absorption spectrophotometer, electronic Analytical balance, ultraviolet analyzer, etc. The equipment used in the research and development of formulations mainly includes multifunctional fluidized beds, rapid stirring granulators, wet and dry granulators, crushing granulators, multi-directional motion mixers, fully automatic capsule filling machines, oscillating screening machines, high-efficiency coating machines, centrifugal screening machines, powder testers, high-speed packaging machines, high-speed tablet presses, high-speed screening machines, vacuum feeding machines, boiling dryers, three-dimensional transparent film packaging machines, and stability test boxes.

R&D Center

The company's R&D center was officially established in 2000 and was certified by a foreign-funded R&D institution in Jiangsu Province in 2008. We are closely cooperating with the global R&D center of our parent company,Dr. Reddy’s Laboratories Ltd. of India, and are committed to providing high-quality and affordable chemical drugs to Chinese patients. The company has a highly specialized research and development technical team, which is well versed in the policies, regulations, technical requirements, and registration requirements in the field of chemical drug research and development. It is fully responsible for the entire process and management of preclinical research, clinical research, pharmaceutical research, drug registration, and obtaining marketing license qualifications. At the same time, the scientific and rigorous management system of the R&D center with clear division of labor ensures the progress, quality, and registration success rate of R&D projects.

Innovation R&D

To further speed up the production of affordable drugs, the R&D center of our company has specially set up five departments, that is, Regulatory Affairs (RA), Formulation Research and Development (FR&D), Analysis, Research and Development (AR&D), Clinical Affairs (CA) and Development Quality Assurance (DQA). All departments work independently andclosely, and complete a wide range of R&D registration and application work efficiently.

KRRP has completed the marketing authorization application for Amlodipine Besylate Atrovastatin Calcium Tablets, Bosentan Tablets and Levetiracetam Tablets, among which Amlodipine Besylate Atrovastatin Calcium Tablets has already passed the on-site inspection for production of drug registration by Center of Drug Evaluation of National Medical Products Administration.